Trade BGLC anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
BioNexus Gene Lab Corp (BGLC) is trading at US$1.45, down 1.36% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$4.66M. Over the past 52 weeks, BGLC has traded between US$1.07 and US$6.10. On Syfe you can trade BGLC with $0 commission and add it to your watchlist.
| Previous close | US$1.47 |
|---|---|
| Market cap | US$4.66M |
| 52-week range | US$1.07 – US$6.10 |
| Volume | 812 |
| Exchange | US |
Add to Watchlist
Set Price Alert
BioNexus Gene Lab Corp
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.
Year: 2020
BioNexus Gene Lab Corp (BGLC) stock is trading at US$1.45, -1.36% from the previous close of US$1.47.
The market cap for BioNexus Gene Lab Corp (BGLC) stock is approximately US$4.66M.
The 52-week high for BioNexus Gene Lab Corp (BGLC) stock is US$6.10.
The 52-week low for BioNexus Gene Lab Corp (BGLC) stock is US$1.07.
BioNexus Gene Lab Corp (BGLC) does not currently pay a dividend.
Stay on top of BGLC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
